Iterum Therapeutics Plc (ITRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -103,130 | -77,056 | -29,406 | -13,464 | N/A |
| Depreciation Amortization | 514 | 496 | 65 | N/A | N/A |
| Accounts payable and accrued liabilities | 11,446 | 849 | 1,671 | 1,188 | N/A |
| Other Working Capital | 17,899 | -1,603 | -1,604 | 1,818 | N/A |
| Other Operating Activity | -8,651 | 1,424 | -1,330 | -840 | 0 |
| Operating Cash Flow | $-81,922 | $-75,890 | $-30,604 | $-11,298 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 40,125 | -8,568 | -30,775 | N/A | N/A |
| PPE Investments | -24 | -90 | -812 | N/A | N/A |
| Investing Cash Flow | $40,101 | $-8,658 | $-31,587 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 14,507 | N/A | N/A | N/A |
| Debt Repayment | -1,034 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 3,097 | 74,160 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 32,175 | 45,867 | 20,851 | 0 |
| Financing Cash Flow | $2,063 | $120,842 | $45,867 | $20,851 | $N/A |
| Exchange Rate Effect | -22 | -108 | N/A | N/A | N/A |
| Beginning Cash Position | 44,671 | 8,485 | 24,809 | 15,256 | N/A |
| End Cash Position | 4,891 | 44,671 | 8,485 | 24,809 | N/A |
| Net Cash Flow | $-39,780 | $36,186 | $-16,324 | $9,553 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -81,922 | -75,890 | -30,604 | -11,298 | N/A |
| Capital Expenditure | -24 | -90 | -812 | N/A | N/A |
| Free Cash Flow | -81,946 | -75,980 | -31,416 | -11,298 | 0 |